What is Osimertinib 80 mg Tablet?
Osimertinib 80 mg Tablet is a highly effective, targeted therapy used in the treatment of non-small cell lung cancer (NSCLC), particularly in patients with EGFR (epidermal growth factor receptor) mutations. Osimertinib works by selectively inhibiting mutated EGFR proteins that promote cancer cell growth. It is commonly prescribed for patients who have either newly diagnosed metastatic NSCLC with EGFR mutations or those who have developed resistance to previous EGFR inhibitors due to the T790M mutation.
As part of a newer class of cancer treatments called tyrosine kinase inhibitors (TKIs), Osimertinib offers a more focused approach to treating advanced lung cancer, aiming to reduce side effects while effectively targeting cancer cells.
Key Features of Generic Osimertinib 80mg Tablet:
- Active Ingredient: Osimertinib 80 mg per tablet.
- Indications: Primarily used for the treatment of metastatic NSCLC with EGFR mutations and for patients who develop T790M mutation resistance after prior EGFR inhibitor therapy.
- Mechanism of Action: Osimertinib blocks the activity of the EGFR mutation, inhibiting the signals that drive cancer cell growth and proliferation.
- Dosage: Typically 80 mg once daily. The tablet can be taken with or without food, and should be swallowed whole.
- Packaging: Each bottle contains a 30-day supply of Osimertinib 80 mg tablets.
Potential Side Effects of Generic Osimertinib Tablet:
While Osimertinib is an effective treatment for NSCLC, it may cause side effects. Common side effects include:
- Diarrhea
- Skin rashes
- Fatigue
- Nausea and vomiting
- Loss of appetite
In rare cases, more serious side effects can occur, such as:
- Interstitial lung disease (ILD): A severe lung condition that can affect breathing.
- QT prolongation: An irregular heart rhythm that can lead to serious heart issues.
- Vision problems: Blurred vision or other eye-related issues can sometimes occur.
Patients should contact their healthcare provider if they experience severe side effects or new, unusual symptoms.
Why choose Osimertinib 80 mg Tablet ?
Osimertinib 80 mg Tablet offers significant advancements in the treatment of EGFR mutation-positive non-small cell lung cancer. It not only provides targeted therapy to fight cancer effectively but also addresses resistance caused by the T790M mutation. With its once-daily oral administration and proven benefits in improving patient outcomes, Osimertinib represents a cornerstone of modern cancer care.
Customer Reviews
There are no reviews yet.